A Study of Fosmanogepix in Healthy Adult Chinese Subjects

Main criteria for inclusion and exclusion: * Body mass index (BMI) of 18.0 to 30.0 kg/m2 inclusive, and a total body weight \> 45 kg for females and \> 50 kg for males at Screening. * Subjects who were overtly healthy as determined by medical evaluation, including medical history, physical examination, laboratory tests, vital signs, creatinine, and estimated creatinine clearance (Cockcroft-Gault formula). Main exclusion criteria: * Active acute or chronic infection, including, but not limited to upper airway infection, urinary tract infection, or skin infection at Screening. * Any condition possibly affecting drug absorption. * Medical history of neurological disorders including abnormal movements or seizures. * Use of prescription or non-prescription drugs, including vaccines, and dietary and herbal supplements from Screening or within five half-lives (whichever is longer) prior to the first dose of study drug and throughout the study. * Screening supine blood pressure (BP) ≥ 140 mmHg (systolic) or ≥ 90 mmHg (diastolic), and pulse rate (PR) \> 100 beats per minute (bpm) or \< 50 bpm, following at least 5 minutes of supine rest. * Body temperature higher than 37.5 °C. * Screening supine 12 lead ECG demonstrating clinically relevant abnormalities that may affect subject safety or interpretation of study results. * Subjects with any of the following abnormalities in clinical laboratory tests at Screening, as assessed by the local laboratory and confirmed by a single repeat t…